120022-63-1 Usage
Uses
Used in Pharmaceutical Industry:
2,5-Difluorobenzenesulfonamide is used as an intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs. Its sulfonamide functional group is known for its antibacterial and antifungal properties, making it a valuable component in the treatment of a range of infections.
Used in Agrochemical Industry:
In the agrochemical sector, 2,5-difluorobenzenesulfonamide serves as an intermediate in the production of agrochemicals, potentially enhancing crop protection and management through its incorporation into pesticides or fungicides.
Used in Organic Chemistry Research:
2,5-Difluorobenzenesulfonamide is utilized as a research compound in organic chemistry, where its unique structure allows for exploration of new reactions and the synthesis of novel organic compounds.
Used in Materials Science:
Its application in materials science may involve the development of new materials with specific properties,得益于其独特的化学结构和特性, 2,5-Difluorobenzenesulfonamide可能有助于开发具有特定属性的新材料。
It is crucial to handle 2,5-difluorobenzenesulfonamide with care, as it may pose health risks if ingested or inhaled, highlighting the need for proper safety measures during its use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 120022-63-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,0,2 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 120022-63:
(8*1)+(7*2)+(6*0)+(5*0)+(4*2)+(3*2)+(2*6)+(1*3)=51
51 % 10 = 1
So 120022-63-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H5F2NO2S/c7-4-1-2-5(8)6(3-4)12(9,10)11/h1-3H,(H2,9,10,11)
120022-63-1Relevant academic research and scientific papers
Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them
-
Page/Page column 4, (2010/02/17)
Compounds of formula (I): wherein: RCy represents an unsubstituted or substituted cycloalkyl group or cycloalkylalkyl group,R1, R2, R3 and R4, which may be the same or different, each represent a hydrogen or halogen atom or a nitro group; a cyano group; a hydroxy group; an alkoxy group; an alkyl group; an unsubstituted or substituted amino group; a carboxy group; an alkoxycarbonyl group; an aryloxycarbonyl group; an unsubstituted or substituted aminocarbonyl group. Medicinal products containing the same which are useful in treating or preventing conditions treatable by an AMPA receptor modulator.
